HUMAN IMMUNOGLOBULIN (PH4) FOR INTRAVENOUS INJECTION MARKET ANALYSIS

Global Human Immunoglobulin Ph4 For Intravenous Injection Market Segmentation:

The global human immunoglobulin ph4 for intravenous injection market report is segmented into product type, interface, end user, and region.

By Product Type, the market is segmented into IgG, IgA, and IgM. Out of which, the igG segment is expected to hold a dominant position in the global human immunoglobulin ph4 for intravenous injection market during the forecast period and this is attributed to their higher affinity and ability to neutralize toxins, viruses, and bacteria.

By Disease Indication, the market is segmented into COVID-19, Primary Immunodeficiency Disease, Immune-mediated Thrombocytopenia, Kawasaki Disease, B Chronic lymphocytic Leukemia(B-CLL), and Others. Out of which, the COVID-19 segment is expected to hold a dominant position in the global human immunoglobulin ph4 for intravenous injection market during the forecast period and this is attributed to the rising cases of coronavirus across the globe.

By Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Out of which, the Hospital Pharmacies segment is expected to dominate the market over the forecast period and this is attributed to the growing number of hospitalizations of patients to treat COVID-19 during the pandemic.

By Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Out of which North America segment is expected to dominate the market owing to the highest prevalence of COVID-19 in this region.

Among all the segmentations, the disease indication segment has the highest potential due to the increasing cases of COVID-19 across the world. For instance, according to the data published by The World Health Organization- a specialized agency of the United Nations responsible for international public health, on May 4, 2023, nearly 2.8 million new cases of coronavirus and over 17, 000 COVID-related deaths were reported between 3 to 30 April 2023.

Global Human Immunoglobulin Ph4 For Intravenous Injection Market Cross Sectional Analysis:

Among product type, IgG segment is expected to dominate in North America region during the forecast period owing to the reliance of patients on IgG Therapy for treating various illnesses. For instance, according to data published in December 2022, in PubMed- a free search engine for biological databases and medical reports, over 40% of adults with generalized myasthenia gravis (gMG) in the U.S. who had been prescribed a  treatment of intravenous immunoglobulin (IVIG), became frequent users with an average of 6 doses administered each year.